{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:46:17Z","timestamp":1791395177470,"version":"4.3.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1245\/s10434-025-17811-x","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T17:06:11Z","timestamp":1752685571000},"page":"7163-7172","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Blurring the Anatomical Lines in Extrahepatic Cholangiocarcinoma: An Integrated Clinic-Oncological and Exploratory Proteomic Comparison of Perihilar and Distal Tumors"],"prefix":"10.1245","volume":"32","author":[{"given":"A.","family":"Marichez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. A.","family":"Raymond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Boubaddi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Toussaint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Le Bail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Belleann\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Di Tommaso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. W.","family":"Dupuy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Dourthe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Decraecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Saltel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Chiche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"issue":"9","key":"17811_CR1","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales JM, Marin JJG, Lamarca A, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020;17(9):557\u201388. https:\/\/doi.org\/10.1038\/s41575-020-0310-z.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"issue":"5","key":"17811_CR2","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/s1470-2045(18)30915-x","volume":"20","author":"JN Primrose","year":"2019","unstructured":"Primrose JN, Fox RP, Palmer DH, et al. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Lancet Oncol. 2019;20(5):663\u201373. https:\/\/doi.org\/10.1016\/s1470-2045(18)30915-x.","journal-title":"Lancet Oncol."},{"issue":"8","key":"17811_CR3","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1200\/jco.18.00050","volume":"37","author":"J Edeline","year":"2019","unstructured":"Edeline J, Benabdelghani M, Bertaut A, et al. Gemcitabine and oxaliplatin chemotherapy or surveillance in resected biliary tract cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): a randomized phase III study. J Clin Oncol. 2019;37(8):658\u201367. https:\/\/doi.org\/10.1200\/jco.18.00050.","journal-title":"J Clin Oncol."},{"issue":"10372","key":"17811_CR4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/s0140-6736(22)02038-4","volume":"401","author":"K Nakachi","year":"2023","unstructured":"Nakachi K, Ikeda M, Konishi M, et al. Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet. 2023;401(10372):195\u2013203. https:\/\/doi.org\/10.1016\/s0140-6736(22)02038-4.","journal-title":"Lancet."},{"issue":"5","key":"17811_CR5","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1097\/hep.0000000000000046","volume":"77","author":"H Jeong","year":"2023","unstructured":"Jeong H, Kim K, Jeong JH, et al. Adjuvant gemcitabine plus cisplatin versus capecitabine in node-positive extrahepatic cholangiocarcinoma: the STAMP randomized trial. Hepatology. 2023;77(5):1540\u20139. https:\/\/doi.org\/10.1097\/hep.0000000000000046.","journal-title":"Hepatology."},{"issue":"9","key":"17811_CR6","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.ejso.2015.05.013","volume":"41","author":"G Ercolani","year":"2015","unstructured":"Ercolani G, Dazzi A, Giovinazzo F, et al. Intrahepatic, peri-hilar and distal cholangiocarcinoma: three different locations of the same tumor or three different tumors? European J Surg Oncol Ejso. 2015;41(9):1162\u20139. https:\/\/doi.org\/10.1016\/j.ejso.2015.05.013.","journal-title":"European J Surg Oncol Ejso."},{"issue":"3","key":"17811_CR7","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.hpb.2019.07.011","volume":"22","author":"E Roos","year":"2020","unstructured":"Roos E, Strijker M, Franken LC, et al. Comparison of short- and long-term outcomes between anatomical subtypes of resected biliary tract cancer in a Western high-volume center. HPB. 2020;22(3):405\u201314. https:\/\/doi.org\/10.1016\/j.hpb.2019.07.011.","journal-title":"HPB."},{"issue":"11","key":"17811_CR8","doi-asserted-by":"publisher","first-page":"4171","DOI":"10.1245\/s10434-020-08534-2","volume":"27","author":"Y Nakanishi","year":"2020","unstructured":"Nakanishi Y, Okamura K, Tsuchikawa T, et al. Time to recurrence after surgical resection and survival after recurrence among patients with perihilar and distal cholangiocarcinomas. Ann Surg Oncol. 2020;27(11):4171\u201380. https:\/\/doi.org\/10.1245\/s10434-020-08534-2.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"17811_CR9","doi-asserted-by":"publisher","first-page":"100","DOI":"10.4174\/astr.2022.102.2.100","volume":"102","author":"JM Lee","year":"2022","unstructured":"Lee JM, Kim H, Sohn HJ, et al. Comparison of oncologic outcomes of extrahepatic cholangiocarcinoma according to tumor location: perihilar cholangiocarcinoma versus distal bile duct cancer. Ann Surg Treat Res. 2022;102(2):100\u20139. https:\/\/doi.org\/10.4174\/astr.2022.102.2.100.","journal-title":"Ann Surg Treat Res."},{"key":"17811_CR10","doi-asserted-by":"publisher","first-page":"151","DOI":"10.14701\/ahbps.22-090","volume":"27","author":"H Ali","year":"2023","unstructured":"Ali H, Zweigle J, Patel P, Tedder B, Khan R, Agrawal S. Survival analysis of extrahepatic cholangiocarcinoma based on surveillance, epidemiology, and end results database. Ann Hepato-Biliary-Pancreat Surg. 2023;27:151\u20137. https:\/\/doi.org\/10.14701\/ahbps.22-090.","journal-title":"Ann Hepato-Biliary-Pancreat Surg."},{"issue":"2","key":"17811_CR11","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jhep.2020.03.008","volume":"73","author":"R Montal","year":"2020","unstructured":"Montal R, Sia D, Montironi C, et al. Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma. J Hepatol. 2020;73(2):315\u201327. https:\/\/doi.org\/10.1016\/j.jhep.2020.03.008.","journal-title":"J Hepatol."},{"key":"17811_CR12","doi-asserted-by":"publisher","DOI":"10.21037\/jgo-21-776","author":"Y Zheng","year":"2021","unstructured":"Zheng Y, Qin Y, Gong W, et al. Specific genomic alterations and prognostic analysis of perihilar cholangiocarcinoma and distal cholangiocarcinoma. J Gastrointest Oncol. 2021. https:\/\/doi.org\/10.21037\/jgo-21-776.","journal-title":"J Gastrointest Oncol."},{"issue":"12","key":"17811_CR13","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1080\/14728222.2021.2013801","volume":"25","author":"M Simbolo","year":"2021","unstructured":"Simbolo M, Bersani S, Vicentini C, et al. Molecular characterization of extrahepatic cholangiocarcinoma: perihilar and distal tumors display divergent genomic and transcriptomic profiles. Expert Opin Ther Tar. 2021;25(12):1095\u2013105. https:\/\/doi.org\/10.1080\/14728222.2021.2013801.","journal-title":"Expert Opin Ther Tar."},{"issue":"1","key":"17811_CR14","doi-asserted-by":"publisher","DOI":"10.1200\/po.24.00206","volume":"8","author":"WA Preston","year":"2024","unstructured":"Preston WA, Drill E, Boerner T, et al. Extrahepatic cholangiocarcinoma: genomic variables associated with anatomic location and outcome. JCO Precis Oncol. 2024;8(1):e2400206. https:\/\/doi.org\/10.1200\/po.24.00206.","journal-title":"JCO Precis Oncol."},{"issue":"2","key":"17811_CR15","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/hep.32624","volume":"77","author":"M Deng","year":"2022","unstructured":"Deng M, Ran P, Chen L, et al. Proteogenomic characterization of cholangiocarcinoma. Hepatology. 2022;77(2):411\u201329. https:\/\/doi.org\/10.1002\/hep.32624.","journal-title":"Hepatology."},{"issue":"1","key":"17811_CR16","doi-asserted-by":"publisher","first-page":"1800128","DOI":"10.1002\/prca.201800128","volume":"13","author":"JL Faouder","year":"2019","unstructured":"Faouder JL, Gigante E, L\u00e9ger T, et al. Proteomic landscape of cholangiocarcinomas reveals three different subgroups according to their localization and the aspect of non-tumor liver. Proteom Clin Appl. 2019;13(1):1800128. https:\/\/doi.org\/10.1002\/prca.201800128.","journal-title":"Proteom Clin Appl."},{"issue":"8","key":"17811_CR17","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.hpb.2023.04.003","volume":"25","author":"A Marichez","year":"2023","unstructured":"Marichez A, Adam JP, Mauriac P, et al. Preemptive wirsungostomy: a safe fistula for avoiding a dreadful fistula in elective or planned pancreatoduodenectomy. HPB. 2023;25(8):881\u20139. https:\/\/doi.org\/10.1016\/j.hpb.2023.04.003.","journal-title":"HPB."},{"issue":"2","key":"17811_CR18","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205\u201313. https:\/\/doi.org\/10.1097\/01.sla.0000133083.54934.ae.","journal-title":"Ann Surg."},{"issue":"3","key":"17811_CR19","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1002\/hep.31826","volume":"74","author":"C Dourthe","year":"2021","unstructured":"Dourthe C, Julien C, Tommaso SD, et al. Proteomic profiling of hepatocellular adenomas paves the way to new diagnostic and prognostic approaches. Hepatology. 2021;74(3):1595\u2013610. https:\/\/doi.org\/10.1002\/hep.31826.","journal-title":"Hepatology."},{"issue":"3","key":"17811_CR20","doi-asserted-by":"publisher","first-page":"569","DOI":"10.3390\/biomedicines10030569","volume":"10","author":"B Chauveau","year":"2022","unstructured":"Chauveau B, Raymond AA, Tommaso SD, et al. The proteome of antibody-mediated rejection: from glomerulitis to transplant glomerulopathy. Biomed. 2022;10(3):569. https:\/\/doi.org\/10.3390\/biomedicines10030569.","journal-title":"Biomed."},{"issue":"5","key":"17811_CR21","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1080\/13651820802276630","volume":"10","author":"PJ Allen","year":"2008","unstructured":"Allen PJ, Reiner AS, Gonen M, et al. Extrahepatic cholangiocarcinoma: a comparison of patients with resected proximal and distal lesions. HPB. 2008;10(5):341\u20136. https:\/\/doi.org\/10.1080\/13651820802276630.","journal-title":"HPB."},{"issue":"3","key":"17811_CR22","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1177\/1457496919832150","volume":"109","author":"V Sallinen","year":"2019","unstructured":"Sallinen V, Sir\u00e9n J, M\u00e4kisalo H, et al. Differences in prognostic factors and recurrence patterns after curative-intent resection of perihilar and distal cholangiocarcinomas. Scand J Surg. 2019;109(3):219\u201327. https:\/\/doi.org\/10.1177\/1457496919832150.","journal-title":"Scand J Surg."},{"issue":"1","key":"17811_CR23","doi-asserted-by":"publisher","first-page":"133","DOI":"10.5604\/16652681.1226927","volume":"16","author":"D Waseem","year":"2017","unstructured":"Waseem D, Tushar P. Intrahepatic, perihilar and distal cholangiocarcinoma: management and outcomes. Ann Hepatol. 2017;16(1):133\u20139. https:\/\/doi.org\/10.5604\/16652681.1226927.","journal-title":"Ann Hepatol."},{"issue":"4","key":"17811_CR24","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/bjs.9752","volume":"102","author":"M Kiriyama","year":"2015","unstructured":"Kiriyama M, Ebata T, Aoba T, et al. Prognostic impact of lymph node metastasis in distal cholangiocarcinoma. Brit J Surg. 2015;102(4):399\u2013406. https:\/\/doi.org\/10.1002\/bjs.9752.","journal-title":"Brit J Surg."},{"issue":"1","key":"17811_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.surg.2023.03.013","volume":"174","author":"I Hosokawa","year":"2023","unstructured":"Hosokawa I, Takayashiki T, Kuboki S, et al. Prognostic impact of proximal ductal margin status in perihilar cholangiocarcinoma according to the presence or absence of lymph node metastasis. Surgery. 2023;174(1):11\u201320. https:\/\/doi.org\/10.1016\/j.surg.2023.03.013.","journal-title":"Surgery."},{"issue":"10","key":"17811_CR26","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1001\/jamasurg.2016.1769","volume":"151","author":"F Giuliante","year":"2016","unstructured":"Giuliante F, Ardito F, Guglielmi A, et al. Association of lymph node status with survival in patients after liver resection for hilar cholangiocarcinoma in an Italian multicenter analysis. JAMA Surg. 2016;151(10):916. https:\/\/doi.org\/10.1001\/jamasurg.2016.1769.","journal-title":"JAMA Surg."},{"issue":"5","key":"17811_CR27","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.jamcollsurg.2016.02.012","volume":"222","author":"F Bagante","year":"2016","unstructured":"Bagante F, Tran T, Spolverato G, et al. Perihilar cholangiocarcinoma: number of nodes examined and optimal lymph node prognostic scheme. J Am Coll Surg. 2016;222(5):750-759.e2. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2016.02.012.","journal-title":"J Am Coll Surg."},{"issue":"2","key":"17811_CR28","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.hpb.2024.11.007","volume":"27","author":"J Kawashima","year":"2025","unstructured":"Kawashima J, Altaf A, Endo Y, et al. Lymphadenectomy for perihilar cholangiocarcinoma: therapeutic benefit of lymph node number and station. HPB. 2025;27(2):250\u20139. https:\/\/doi.org\/10.1016\/j.hpb.2024.11.007.","journal-title":"HPB."},{"issue":"12","key":"17811_CR29","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.3390\/jcm4121958","volume":"4","author":"S Brivio","year":"2015","unstructured":"Brivio S, Cadamuro M, Fabris L, Strazzabosco M. epithelial-to-mesenchymal transition and cancer invasiveness: what can we learn from cholangiocarcinoma? J Clin Med. 2015;4(12):2028\u201341. https:\/\/doi.org\/10.3390\/jcm4121958.","journal-title":"J Clin Med."},{"issue":"2","key":"17811_CR30","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.jhep.2016.09.010","volume":"66","author":"J Vaquero","year":"2017","unstructured":"Vaquero J, Guedj N, Clap\u00e9ron A, Ho-Bouldoires THN, Paradis V, Fouassier L. Epithelial-mesenchymal transition in cholangiocarcinoma: from clinical evidence to regulatory networks. J Hepatol. 2017;66(2):424\u201341. https:\/\/doi.org\/10.1016\/j.jhep.2016.09.010.","journal-title":"J Hepatol."},{"issue":"3","key":"17811_CR31","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.21037\/jgo-22-1126","volume":"14","author":"P Kimawaha","year":"2023","unstructured":"Kimawaha P, Techasen A. The novel epithelial-mesenchymal transition-related proteins and their therapeutic targets in cholangiocarcinoma: a narrative review. J Gastrointest Oncol. 2023;14(3):1593\u2013612. https:\/\/doi.org\/10.21037\/jgo-22-1126.","journal-title":"J Gastrointest Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17811-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-17811-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17811-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T14:06:15Z","timestamp":1758549975000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-17811-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["17811"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-17811-x","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,16]]},"assertion":[{"value":"12 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}